デフォルト表紙
市場調査レポート
商品コード
1469122

POC(ポイントオブケア)診断の世界市場 - 産業規模、シェア、動向、機会、予測:製品別、プラットフォーム別、購入形態別、エンドユーザー別、地域別、競合別(2019年~2029年)

Point of Care Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Platform, By Mode Of Purchase, By End User, By Region and Competition, 2019-2029F

出版日: | 発行: TechSci Research | ページ情報: 英文 181 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.74円

こちらのレポートには、数時間(ご購入金額の10%)分のアナリストへの質問/追加調査サービスが含まれております。

POC(ポイントオブケア)診断の世界市場 - 産業規模、シェア、動向、機会、予測:製品別、プラットフォーム別、購入形態別、エンドユーザー別、地域別、競合別(2019年~2029年)
出版日: 2024年04月23日
発行: TechSci Research
ページ情報: 英文 181 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 目次
概要

世界のPOC(ポイントオブケア)診断の市場規模は、2023年に431億2,000万米ドルに達し、2029年までのCAGRは9.18%で、予測期間中に力強い成長を遂げると予測されています。 世界のPOC(ポイントオブケア)診断市場は、分散型で迅速な診断ソリューションが重視されるようになったことを反映し、近年著しい成長と変貌を遂げています。

この市場は、技術の進歩と即時かつ現場での医療結果に対する需要に牽引され、患者のいる場所またはその近くで使用するように設計された幅広い診断機器を包含しています。特に、従来の検査室での検査が実用的でなかったり、時間がかかったりするような環境では、タイムリーで実用的な情報を提供する上で、POC診断が重要な役割を果たします。この市場には、グルコースメーター、妊娠検査、感染症検査、心臓マーカーなど、多様な製品が含まれます。慢性疾患の蔓延に加え、迅速かつ効率的な診断ツールの必要性が高まっていることが、さまざまなヘルスケア環境でのポイントオブケア検査の採用に拍車をかけています。市場拡大を促進する主な要因としては、疾病の早期発見の利点に対する認識の高まり、感染症による世界の負担の増加、個別化医療に向けた動向の高まりなどが挙げられます。COVID-19の大流行は、迅速診断ソリューションへの需要をさらに加速させ、公衆衛生の危機管理におけるPOC診断の重要な役割を浮き彫りにしています。バイオセンサーの統合、機器の小型化、ユーザーフレンドリーなインターフェースの開発などの技術の進歩により、POC診断機器の性能とアクセシビリティが向上しています。

市場促進要因

慢性疾患の有病率の上昇

即時結果とオンサイト検査への需要

POC(ポイントオブケア)機器の技術的進歩

主な市場課題

規制上のハードルと標準化

品質と精度に関する懸念

主な市場動向

デジタルヘルス技術の統合

バイオセンサー技術の急速な進歩

セグメント別の洞察

製品別の洞察

プラットフォーム別の洞察

地域別の洞察

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 POC診断の世界市場展望

  • 市場規模予測
    • 金額別
  • 市場シェア予測
    • 製品別(グルコースモニタリング製品、循環代謝モニタリング製品、感染症検査製品、凝固モニタリング製品、COVID-19検査製品、その他)
    • プラットフォーム別(ラテラルフローアッセイ、ディップスティック、マイクロフルイディクス、分子診断、イムノアッセイ)
    • 購入形態別(処方箋ベース製品、OTC製品)
    • エンドユーザー別(病院・クリニック、外来手術センター、その他)
    • 地域別
    • 企業別(2023年)
  • 市場マップ
    • 製品別
    • プラットフォーム別
    • 購入形態別
    • エンドユーザー別
    • 地域別

第5章 アジア太平洋のPOC診断市場の展望

  • 市場規模予測
    • 金額別
  • 市場シェア予測
    • 製品別
    • プラットフォーム別
    • 購入形態別
    • エンドユーザー別
    • 国別
  • アジア太平洋:国別分析
    • 中国
    • インド
    • オーストラリア
    • 日本
    • 韓国

第6章 欧州のPOC診断市場の展望

  • 市場規模予測
    • 金額別
  • 市場シェア予測
    • 製品別
    • プラットフォーム別
    • 購入形態別
    • エンドユーザー別
    • 国別
  • 欧州:国別分析
    • フランス
    • ドイツ
    • スペイン
    • イタリア
    • 英国

第7章 北米のPOC診断市場の展望

  • 市場規模予測
    • 金額別
  • 市場シェア予測
    • 製品別
    • プラットフォーム別
    • 購入形態別
    • エンドユーザー別
    • 国別
  • 北米:国別分析
    • 米国
    • メキシコ
    • カナダ

第8章 南米のPOC診断市場の展望

  • 市場規模予測
    • 金額別
  • 市場シェア予測
    • 製品別
    • プラットフォーム別
    • 購入形態別
    • エンドユーザー別
    • 国別
  • 南米:国別分析
    • ブラジル
    • アルゼンチン
    • コロンビア

第9章 中東・アフリカのPOC診断市場の展望

  • 市場規模予測
    • 金額別
  • 市場シェア予測
    • 製品別
    • プラットフォーム別
    • 購入形態別
    • エンドユーザー別
    • 国別
  • 中東・アフリカ:国別分析
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • エジプト

第10章 市場力学

  • 促進要因
  • 課題

第11章 市場動向発展

  • 最近の動向
  • 製品発表
  • 合併・買収

第12章 POC(ポイントオブケア)診断薬の世界市場:SWOT分析

第13章 ポーターのファイブフォース分析

  • 業界内の競合
  • 新規参入の可能性
  • サプライヤーの力
  • 顧客の力
  • 代替品の脅威

第14章 競合情勢

  • EKF Diagnostics
  • Abbott Laboratories Inc.
  • Siemens Healthineers Ag
  • F. Hoffmann-La Roche Ltd
  • Quidel Corporation
  • Danaher Corporation
  • Becton, Dickinson and Company
  • Thermo Fisher Scientific Inc
  • Biomerieux S.A.
  • Chembio Diagnostics, Inc.

第15章 戦略的提言

第16章 調査会社について・免責事項

目次
Product Code: 23497

Global Point of Care Diagnostics Market was valued at USD 43.12 billion in 2023 and is anticipated to project robust growth in the forecast period with a CAGR of 9.18% through 2029. The Global Point of Care Diagnostics Market has witnessed significant growth and transformation in recent years, reflecting the increasing emphasis on decentralized and rapid diagnostic solutions. This market, driven by technological advancements and the demand for immediate and on-site medical results, encompasses a wide array of diagnostic devices designed for use at or near the patient's location. Point of care diagnostics plays a crucial role in delivering timely and actionable information, particularly in settings where traditional laboratory testing may be impractical or time-consuming. The market includes a diverse range of products such as glucose meters, pregnancy tests, infectious disease tests, cardiac markers, and more. The growing prevalence of chronic diseases, coupled with the need for quick and efficient diagnostic tools, has fueled the adoption of point-of-care testing across various healthcare settings. Key factors driving the market's expansion include the increasing awareness of the benefits of early disease detection, the rising global burden of infectious diseases, and the growing trend towards personalized medicine. The COVID-19 pandemic has further accelerated the demand for rapid diagnostic solutions, highlighting the crucial role of point-of-care diagnostics in managing public health crises. Advancements in technology, such as the integration of biosensors, miniaturization of devices, and the development of user-friendly interfaces, have enhanced the performance and accessibility of point-of-care diagnostic devices.

Key Market Drivers

Rising Prevalence of Chronic Diseases

The escalating prevalence of chronic diseases globally stands out as a primary driver propelling the growth of the Global Point of Care Diagnostics Market. Chronic conditions such as diabetes, cardiovascular diseases, and respiratory disorders have become increasingly prevalent, posing significant challenges to healthcare systems worldwide. This surge in chronic illnesses has created a pressing need for efficient and timely diagnostic solutions, a demand that point-of-care diagnostics effectively addresses. These diagnostic tools offer the advantage of immediate testing at or near the patient's location, enabling swift detection of biomarkers associated with chronic diseases. By providing rapid results, point-of-care diagnostics facilitate early intervention and contribute to improved management of chronic conditions.

The burden of chronic diseases is particularly pronounced in aging populations, where the risk of developing such conditions is higher. As demographics shift towards an older age structure globally, the demand for point-of-care diagnostics becomes even more pronounced. These diagnostic tools empower healthcare professionals to promptly identify and monitor chronic diseases, allowing for timely adjustments to treatment plans and lifestyle interventions. The ability to obtain real-time information through point-of-care testing enhances the overall efficiency of healthcare delivery, leading to better patient outcomes.

The rising prevalence of chronic diseases is associated with an increased focus on preventive healthcare and early disease detection. Point-of-care diagnostics align perfectly with these objectives, as they enable healthcare providers to conduct immediate testing and deliver prompt results. This proactive approach to healthcare is crucial in managing chronic conditions, where early intervention can significantly impact disease progression and improve the quality of life for patients.

The COVID-19 pandemic has further underscored the importance of rapid diagnostics, amplifying the significance of point-of-care testing in addressing not only infectious diseases but also chronic conditions. As healthcare systems recalibrate their priorities to accommodate the dual challenges of infectious and chronic diseases, the role of point-of-care diagnostics becomes pivotal. The market is witnessing increased investment in research and development to enhance the capabilities of these diagnostic tools, ensuring they meet the evolving demands of a healthcare landscape marked by the rising prevalence of chronic diseases.

Demand for Immediate Results and On-Site Testing

The Global Point of Care Diagnostics Market is experiencing a significant boost driven by the increasing demand for immediate results and on-site testing. In an era where time is a critical factor in healthcare decision-making, the need for swift diagnostic outcomes has become paramount. Point-of-care diagnostics, with its capacity to deliver rapid results directly at the patient's location, addresses this imperative. The demand for immediate results is particularly evident in emergency and critical care settings, where timely diagnosis can be a matter of life and death. Point-of-care testing eliminates the delays associated with transporting samples to centralized laboratories, allowing healthcare providers to make quick and informed decisions, leading to more effective patient management.

The convenience and efficiency of on-site testing are reshaping healthcare delivery across various settings. Hospitals, clinics, and even home care environments are increasingly adopting point-of-care diagnostics to streamline the diagnostic process. Patients benefit from reduced waiting times and quicker access to results, leading to a more seamless healthcare experience. This demand is further fueled by the growing emphasis on patient-centered care, where immediate access to diagnostic information empowers individuals to actively participate in their healthcare decisions.

The urgency for on-site testing has been accentuated by the global response to the COVID-19 pandemic. Point-of-care diagnostics played a pivotal role in the rapid identification of the SARS-CoV-2 virus, enabling swift isolation and treatment of affected individuals. This experience has underscored the critical role of immediate results in managing public health crises, further solidifying the position of point-of-care diagnostics as an indispensable tool in infectious disease control.

Technological advancements have played a crucial role in meeting the demand for on-site testing. The miniaturization of diagnostic devices, coupled with the integration of advanced sensors and user-friendly interfaces, has enhanced the performance and accessibility of point-of-care diagnostics. These innovations have enabled healthcare providers to conduct a broad range of tests rapidly and efficiently at the point of care, contributing to the market's growth.

Technological Advancements in Point-of-Care Devices

Technological advancements in point-of-care devices are playing a pivotal role in boosting the Global Point of Care Diagnostics Market, ushering in a new era of efficiency, accuracy, and accessibility in healthcare diagnostics. Innovations such as biosensors, microfluidics, and miniaturized devices have significantly elevated the capabilities of point-of-care diagnostics, driving market growth. Biosensors, for example, enable the rapid and sensitive detection of specific biomarkers, enhancing the diagnostic accuracy of these devices. The miniaturization of diagnostic tools not only facilitates portability but also contributes to the development of user-friendly, handheld devices that can be easily operated by healthcare professionals in diverse settings.

Microfluidics technology has emerged as a key enabler in point-of-care diagnostics, allowing for precise manipulation of small volumes of fluids within micro-scale channels. This technology enhances the sensitivity and specificity of diagnostic tests while reducing the time required for analysis. The integration of microfluidics into point-of-care devices enables complex assays to be performed with minimal sample volumes, making them well-suited for applications in resource-limited settings and scenarios where rapid results are critical.

The incorporation of connectivity features and smartphone applications has transformed point-of-care devices into powerful tools for data management and remote monitoring. These advancements allow healthcare professionals to seamlessly collect, analyze, and share diagnostic information, facilitating collaborative decision-making and improving patient care. The integration of technology has also extended the reach of point-of-care diagnostics beyond traditional healthcare settings, enabling testing in remote or underserved areas.

The ongoing convergence of biotechnology, nanotechnology, and information technology continues to drive innovation in point-of-care diagnostics. The development of lab-on-a-chip technologies, where entire diagnostic processes are integrated onto a single chip, further enhances the speed and efficiency of point-of-care testing. Such advancements not only streamline diagnostic workflows but also contribute to cost-effectiveness and resource efficiency, making point-of-care diagnostics an attractive option for healthcare providers and institutions.

Key Market Challenges

Regulatory Hurdles and Standardization

The Global Point of Care Diagnostics Market, driven by the demand for rapid and decentralized testing solutions, faces significant obstacles stemming from regulatory hurdles and the lack of standardization. This complex regulatory landscape poses a formidable challenge for manufacturers, hindering the timely introduction of innovative products and impeding the overall growth of the market.

The diversity of point-of-care devices and technologies within the market complicates regulatory efforts, as different regions and countries maintain distinct regulatory frameworks. Varying approval processes, documentation requirements, and compliance standards create a labyrinthine landscape for manufacturers seeking global market access. The absence of harmonized regulations not only delays the introduction of new point-of-care devices but also raises the cost of compliance, impacting both manufacturers and end-users.

Standardization, or the lack thereof, further exacerbates challenges in the Global Point of Care Diagnostics Market. The absence of universally accepted protocols for point-of-care devices poses difficulties for interoperability and data exchange between different diagnostic tools and healthcare information systems. This lack of standardization not only hampers the seamless integration of point-of-care results into electronic health records but also complicates the sharing of information among healthcare professionals, impeding collaborative decision-making.

Quality and Accuracy Concerns

Despite the transformative potential of point-of-care diagnostics in providing rapid and decentralized testing solutions, the Global Point of Care Diagnostics Market faces significant challenges related to concerns about the quality and accuracy of test results. Ensuring the reliability of point-of-care tests is paramount to building trust among healthcare providers, regulators, and patients, yet maintaining stringent quality control measures across diverse settings remains a formidable task.

One of the primary concerns revolves around the consistency and accuracy of point-of-care results compared to traditional laboratory testing. While these diagnostics offer the advantage of immediate testing, questions about the reliability of results persist. Variability in environmental conditions, operator proficiency, and device performance can impact the accuracy of point-of-care tests, raising concerns among healthcare professionals and regulatory authorities.

Robust validation processes and ongoing quality assurance initiatives are essential to address these concerns. Manufacturers must invest in comprehensive testing protocols, ensuring that point-of-care devices consistently meet stringent performance standards. The regulatory bodies play a crucial role in establishing and enforcing quality control measures, creating a framework that fosters confidence in the accuracy of point-of-care diagnostics.

The nature of point-of-care testing, often conducted in diverse and resource-limited settings, introduces additional challenges related to maintaining quality and accuracy. Point-of-care devices may be deployed in environments with varying temperatures, humidity levels, and infrastructure capabilities. Adapting to these conditions without compromising the precision of diagnostic results requires innovative engineering solutions and rigorous testing under real-world conditions.

Key Market Trends

Integration of Digital Health Technologies

The integration of digital health technologies is emerging as a pivotal trend, significantly boosting the Global Point of Care Diagnostics Market. This transformative trend represents the convergence of point-of-care diagnostics with innovative digital platforms, including mobile applications and cloud-based systems. The seamless integration of diagnostics and digital health technologies facilitates real-time data sharing, remote monitoring, and enhanced connectivity between point-of-care devices and electronic health records. This synergy not only streamlines the flow of information but also empowers healthcare providers with timely and actionable insights, ultimately improving patient management.

The incorporation of digital health technologies into point-of-care diagnostics brings about a paradigm shift in healthcare delivery. Mobile applications paired with diagnostic devices allow for more accessible and user-friendly interfaces, empowering both healthcare professionals and patients. Patients can actively participate in their healthcare by receiving immediate results and tracking their health data, fostering a sense of engagement and empowerment. For healthcare providers, the integration enables more efficient and coordinated care, as diagnostic information seamlessly integrates into comprehensive electronic health records.

The connectivity facilitated by digital health technologies supports remote monitoring, enabling healthcare professionals to track patients' health status in real-time, especially relevant in chronic disease management. This trend is particularly crucial in the era of telemedicine and virtual care, where point-of-care diagnostics play a central role in expanding healthcare access beyond traditional settings. The ongoing integration of digital health technologies into point-of-care diagnostics is not only enhancing the efficiency and accessibility of medical testing but also contributing to the overall evolution of healthcare systems.

Rapid Advancements in Biosensor Technology

Rapid advancements in biosensor technology have emerged as a transformative force, catalyzing significant growth in the global point-of-care diagnostics market. Biosensors, which combine biological components with transducers to detect and analyze biological markers, have become integral to the development of innovative diagnostic tools that offer quick and accurate results at the point of care. These technological strides have revolutionized healthcare by providing healthcare professionals and patients with timely information for swift decision-making. The global point-of-care diagnostics market has experienced a substantial boost as biosensors continue to evolve, offering enhanced sensitivity, specificity, and portability.

Biosensors enable the development of handheld, user-friendly devices that can detect a wide range of biomarkers, from glucose levels to infectious diseases, in real-time. This shift towards point-of-care diagnostics not only improves patient outcomes but also streamlines healthcare delivery and reduces the burden on traditional laboratory infrastructure. Biosensor technology has played a pivotal role in the continuous monitoring of chronic conditions, enabling personalized and proactive healthcare. Wearable biosensors can track physiological parameters, such as glucose levels, allowing individuals and healthcare professionals to manage chronic diseases more effectively. The integration of biosensors into connected health ecosystems has created a seamless flow of information, empowering patients to actively participate in their healthcare management.

The global point-of-care diagnostics market has witnessed a surge in investment and research collaborations aimed at developing cutting-edge biosensor technologies. Advancements in materials science, nanotechnology, and biochemistry have contributed to the design of biosensors with improved sensitivity and specificity, expanding the range of detectable analytes. As a result, the market is experiencing a proliferation of novel biosensor-based diagnostic devices across various medical fields, including infectious diseases, cardiovascular health, and cancer diagnostics.

Segmental Insights

Product Insights

Based on the Product, glucose monitoring products emerged as the dominant segment in the global market for Global HematologyPoint of Care Diagnostics in 2023.The high demand for glucose monitoring devices is driven by the increasing prevalence of diabetes worldwide. With the growing incidence of diabetes and the need for regular monitoring of blood glucose levels, point-of-care glucose testing devices have become integral in the management of this chronic condition. These devices offer quick and convenient testing, allowing patients to monitor their glucose levels at home or in various healthcare settings. The demand for glucose monitoring products has been further accelerated by technological advancements, such as continuous glucose monitoring systems, which provide real-time data and reduce the need for traditional fingerstick tests.

Platform Insights

Based on the Platform, Lateral Flow Assays emerged as the dominant segment in the global market for Global Point of Care Diagnostics Market in 2023.Lateral flow assays are known for their simplicity, speed, and ease of use. These assays, often in the form of test strips or cartridges, are designed for rapid on-site detection of various analytes. They are widely used in applications like pregnancy tests, infectious disease testing, and cardiac markers. The simplicity of the lateral flow format makes it suitable for point-of-care settings where rapid results are crucial.

Regional Insights

North America emerged as the dominant player in the Global Point of Care Diagnostics Market in 2023, holding the largest market share. North America has been at the forefront of technological advancements in the healthcare sector, and this includes point-of-care diagnostics. The region has a robust infrastructure supporting research and development activities, leading to the introduction of innovative and advanced diagnostic technologies. The continuous integration of cutting-edge technologies enhances the efficiency and accuracy of point-of-care diagnostics, attracting both healthcare providers and patients. The United States, in particular, has one of the highest healthcare expenditures globally. The significant investment in healthcare infrastructure, research, and development creates an environment conducive to the adoption of advanced medical technologies, including point-of-care diagnostics. The willingness to invest in state-of-the-art healthcare solutions contributes to the dominance of North America in the market.

Key Market Players

EKF Diagnostics

Abbott Laboratories Inc.

Siemens Healthineers Ag

F. Hoffmann-La Roche Ltd

Quidel Corporation

Danaher Corporation

Becton, Dickinson and Company

Thermo Fisher Scientific Inc

Biomerieux S.A.

Chembio Diagnostics, Inc

Report Scope:

In this report, the Global Point of Care Diagnostics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Point of Care Diagnostics Market,By Product:

  • Glucose Monitoring Products
  • Cardiometabolic Monitoring Products
  • Infectious Disease Testing Products
  • Coagulation Monitoring products
  • Covid-19 Test Products
  • Others

Point of Care Diagnostics Market,By Platform:

  • Lateral Flow Assays
  • Dipsticks
  • Microfluidics
  • Molecular Diagnostics
  • Immunoassays

Point of Care Diagnostics Market,By Mode of Purchase:

  • Prescription Based Products
  • OTC Products

Point of Care Diagnostics Market,By End User:

  • Hospitals Clinics
  • Ambulatory Surgical Centers
  • Others

Point of Care Diagnostics Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Point of Care Diagnostics Market.

Available Customizations:

Global Point of Care Diagnostics Market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1.Product Overview

  • 1.1.Market Definition
  • 1.2.Scope of the Market
    • 1.2.1.Markets Covered
    • 1.2.2.Years Considered for Study
    • 1.2.3.Key Market Segmentations

2.Research Methodology

  • 2.1.Objective of the Study
  • 2.2.Baseline Methodology
  • 2.3.Key Industry Partners
  • 2.4.Major Association and Secondary Sources
  • 2.5.Forecasting Methodology
  • 2.6.Data Triangulation Validation
  • 2.7.Assumptions and Limitations

3.Executive Summary

  • 3.1.Overview of the Market
  • 3.2.Overview of Key Market Segmentations
  • 3.3.Overview of Key Market Players
  • 3.4.Overview of Key Regions/Countries
  • 3.5.Overview of Market Drivers, Challenges, Trends

4.Global Point of Care Diagnostics Market Outlook

  • 4.1.Market Size Forecast
    • 4.1.1.By Value
  • 4.2.Market Share Forecast
    • 4.2.1.By Product (Glucose Monitoring Products, Cardiometabolic Monitoring Products, infectious Disease Testing Products, Coagulation Monitoring products, Covid-19 Test Products, Others)
    • 4.2.2.By Platform (Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics, Immunoassays)
    • 4.2.3.By Mode Of Purchase (Prescription Based Products, OTC Products)
    • 4.2.4.By End User (Hospitals Clinics, Ambulatory Surgical Centers, Others)
    • 4.2.5.By Region
    • 4.2.6.By Company (2023)
  • 4.3.Market Map
    • 4.3.1.By Product
    • 4.3.2.By Platform
    • 4.3.3.By Mode Of Purchase
    • 4.3.4.By End User
    • 4.3.5.By Region

5.Asia Pacific Point of Care Diagnostics Market Outlook

  • 5.1.Market Size Forecast
    • 5.1.1.By Value
  • 5.2.Market Share Forecast
    • 5.2.1.By Product
    • 5.2.2.By Platform
    • 5.2.3.By Mode Of Purchase
    • 5.2.4.By End User
    • 5.2.5.By Country
  • 5.3.Asia Pacific: Country Analysis
    • 5.3.1.China Point of Care Diagnostics Market Outlook
      • 5.3.1.1.Market Size Forecast
        • 5.3.1.1.1.By Value
      • 5.3.1.2.Market Share Forecast
        • 5.3.1.2.1.By Product
        • 5.3.1.2.2.By Platform
        • 5.3.1.2.3.By Mode Of Purchase
        • 5.3.1.2.4.By End User
    • 5.3.2.India Point of Care Diagnostics Market Outlook
      • 5.3.2.1.Market Size Forecast
        • 5.3.2.1.1.By Value
      • 5.3.2.2.Market Share Forecast
        • 5.3.2.2.1.By Product
        • 5.3.2.2.2.By Platform
        • 5.3.2.2.3.By Mode Of Purchase
        • 5.3.2.2.4.By End User
    • 5.3.3.Australia Point of Care Diagnostics Market Outlook
      • 5.3.3.1.Market Size Forecast
        • 5.3.3.1.1.By Value
      • 5.3.3.2.Market Share Forecast
        • 5.3.3.2.1.By Product
        • 5.3.3.2.2.By Platform
        • 5.3.3.2.3.By Mode Of Purchase
        • 5.3.3.2.4.By End User
    • 5.3.4.Japan Point of Care Diagnostics Market Outlook
      • 5.3.4.1.Market Size Forecast
        • 5.3.4.1.1.By Value
      • 5.3.4.2.Market Share Forecast
        • 5.3.4.2.1.By Product
        • 5.3.4.2.2.By Platform
        • 5.3.4.2.3.By Mode Of Purchase
        • 5.3.4.2.4.By End User
    • 5.3.5.South Korea Point of Care Diagnostics Market Outlook
      • 5.3.5.1.Market Size Forecast
        • 5.3.5.1.1.By Value
      • 5.3.5.2.Market Share Forecast
        • 5.3.5.2.1.By Product
        • 5.3.5.2.2.By Platform
        • 5.3.5.2.3.By Mode Of Purchase
        • 5.3.5.2.4.By End User

6.Europe Point of Care Diagnostics Market Outlook

  • 6.1.Market Size Forecast
    • 6.1.1.By Value
  • 6.2.Market Share Forecast
    • 6.2.1.By Product
    • 6.2.2.By Platform
    • 6.2.3.By Mode Of Purchase
    • 6.2.4.By End User
    • 6.2.5.By Country
  • 6.3.Europe: Country Analysis
    • 6.3.1.France Point of Care Diagnostics Market Outlook
      • 6.3.1.1.Market Size Forecast
        • 6.3.1.1.1.By Value
      • 6.3.1.2.Market Share Forecast
        • 6.3.1.2.1.By Product
        • 6.3.1.2.2.By Platform
        • 6.3.1.2.3.By Mode Of Purchase
        • 6.3.1.2.4.By End User
    • 6.3.2.Germany Point of Care Diagnostics Market Outlook
      • 6.3.2.1.Market Size Forecast
        • 6.3.2.1.1.By Value
      • 6.3.2.2.Market Share Forecast
        • 6.3.2.2.1.By Product
        • 6.3.2.2.2.By Platform
        • 6.3.2.2.3.By Mode Of Purchase
        • 6.3.2.2.4.By End User
    • 6.3.3.Spain Point of Care Diagnostics Market Outlook
      • 6.3.3.1.Market Size Forecast
        • 6.3.3.1.1.By Value
      • 6.3.3.2.Market Share Forecast
        • 6.3.3.2.1.By Product
        • 6.3.3.2.2.By Platform
        • 6.3.3.2.3.By Mode Of Purchase
        • 6.3.3.2.4.By End User
    • 6.3.4.Italy Point of Care Diagnostics Market Outlook
      • 6.3.4.1.Market Size Forecast
        • 6.3.4.1.1.By Value
      • 6.3.4.2.Market Share Forecast
        • 6.3.4.2.1.By Product
        • 6.3.4.2.2.By Platform
        • 6.3.4.2.3.By Mode Of Purchase
        • 6.3.4.2.4.By End User
    • 6.3.5.United Kingdom Point of Care Diagnostics Market Outlook
      • 6.3.5.1.Market Size Forecast
        • 6.3.5.1.1.By Value
      • 6.3.5.2.Market Share Forecast
        • 6.3.5.2.1.By Product
        • 6.3.5.2.2.By Platform
        • 6.3.5.2.3.By Mode Of Purchase
        • 6.3.5.2.4.By End User

7.North America Point of Care Diagnostics Market Outlook

  • 7.1.Market Size Forecast
    • 7.1.1.By Value
  • 7.2.Market Share Forecast
    • 7.2.1.By Product
    • 7.2.2.By Platform
    • 7.2.3.By Mode Of Purchase
    • 7.2.4.By End User
    • 7.2.5.By Country
  • 7.3.North America: Country Analysis
    • 7.3.1.United States Point of Care Diagnostics Market Outlook
      • 7.3.1.1.Market Size Forecast
        • 7.3.1.1.1.By Value
      • 7.3.1.2.Market Share Forecast
        • 7.3.1.2.1.By Product
        • 7.3.1.2.2.By Platform
        • 7.3.1.2.3.By Mode Of Purchase
        • 7.3.1.2.4.By End User
    • 7.3.2.Mexico Point of Care Diagnostics Market Outlook
      • 7.3.2.1.Market Size Forecast
        • 7.3.2.1.1.By Value
      • 7.3.2.2.Market Share Forecast
        • 7.3.2.2.1.By Product
        • 7.3.2.2.2.By Platform
        • 7.3.2.2.3.By Mode Of Purchase
        • 7.3.2.2.4.By End User
    • 7.3.3.Canada Point of Care Diagnostics Market Outlook
      • 7.3.3.1.Market Size Forecast
        • 7.3.3.1.1.By Value
      • 7.3.3.2.Market Share Forecast
        • 7.3.3.2.1.By Product
        • 7.3.3.2.2.By Platform
        • 7.3.3.2.3.By Mode Of Purchase
        • 7.3.3.2.4.By End User

8.South America Point of Care Diagnostics Market Outlook

  • 8.1.Market Size Forecast
    • 8.1.1.By Value
  • 8.2.Market Share Forecast
    • 8.2.1.By Product
    • 8.2.2.By Platform
    • 8.2.3.By Mode Of Purchase
    • 8.2.4.By End User
    • 8.2.5.By Country
  • 8.3.South America: Country Analysis
    • 8.3.1.Brazil Point of Care Diagnostics Market Outlook
      • 8.3.1.1.Market Size Forecast
        • 8.3.1.1.1.By Value
      • 8.3.1.2.Market Share Forecast
        • 8.3.1.2.1.By Product
        • 8.3.1.2.2.By Platform
        • 8.3.1.2.3.By Mode Of Purchase
        • 8.3.1.2.4.By End User
    • 8.3.2.Argentina Point of Care Diagnostics Market Outlook
      • 8.3.2.1.Market Size Forecast
        • 8.3.2.1.1.By Value
      • 8.3.2.2.Market Share Forecast
        • 8.3.2.2.1.By Product
        • 8.3.2.2.2.By Platform
        • 8.3.2.2.3.By Mode Of Purchase
        • 8.3.2.2.4.By End User
    • 8.3.3.Colombia Point of Care Diagnostics Market Outlook
      • 8.3.3.1.Market Size Forecast
        • 8.3.3.1.1.By Value
      • 8.3.3.2.Market Share Forecast
        • 8.3.3.2.1.By Product
        • 8.3.3.2.2.By Platform
        • 8.3.3.2.3.By Mode Of Purchase
        • 8.3.3.2.4.By End User

9.Middle East and Africa Point of Care Diagnostics Market Outlook

  • 9.1.Market Size Forecast
    • 9.1.1.By Value
  • 9.2.Market Share Forecast
    • 9.2.1.By Product
    • 9.2.2.By Platform
    • 9.2.3.By Mode Of Purchase
    • 9.2.4.By End User
    • 9.2.5.By Country
  • 9.3.MEA: Country Analysis
    • 9.3.1.South Africa Point of Care Diagnostics Market Outlook
      • 9.3.1.1.Market Size Forecast
        • 9.3.1.1.1.By Value
      • 9.3.1.2.Market Share Forecast
        • 9.3.1.2.1.By Product
        • 9.3.1.2.2.By Platform
        • 9.3.1.2.3.By Mode Of Purchase
        • 9.3.1.2.4.By End User
    • 9.3.2.Saudi Arabia Point of Care Diagnostics Market Outlook
      • 9.3.2.1.Market Size Forecast
        • 9.3.2.1.1.By Value
      • 9.3.2.2.Market Share Forecast
        • 9.3.2.2.1.By Product
        • 9.3.2.2.2.By Platform
        • 9.3.2.2.3.By Mode Of Purchase
        • 9.3.2.2.4.By End User
    • 9.3.3.UAE Point of Care Diagnostics Market Outlook
      • 9.3.3.1.Market Size Forecast
        • 9.3.3.1.1.By Value
      • 9.3.3.2.Market Share Forecast
        • 9.3.3.2.1.By Product
        • 9.3.3.2.2.By Platform
        • 9.3.3.2.3.By Mode Of Purchase
        • 9.3.3.2.4.By End User
    • 9.3.4.Egypt Point of Care Diagnostics Market Outlook
      • 9.3.4.1.Market Size Forecast
        • 9.3.4.1.1.By Value
      • 9.3.4.2.Market Share Forecast
        • 9.3.4.2.1.By Product
        • 9.3.4.2.2.By Platform
        • 9.3.4.2.3.By Mode Of Purchase
        • 9.3.4.2.4.By End User

10.Market Dynamics

  • 10.1.Drivers
  • 10.2.Challenges

11.Market Trends Developments

  • 11.1.Recent Developments
  • 11.2.Product Launches
  • 11.3.Mergers Acquisitions

12.Global Point of Care Diagnostics Market: SWOT Analysis

13.Porter's Five Forces Analysis

  • 13.1.Competition in the Industry
  • 13.2.Potential of New Entrants
  • 13.3.Power of Suppliers
  • 13.4.Power of Customers
  • 13.5.Threat of Substitute Product

14.Competitive Landscape

  • 14.1.EKF Diagnostics
    • 14.1.1.Business Overview
    • 14.1.2.Company Snapshot
    • 14.1.3.Products Services
    • 14.1.4.Financials (In case of listed)
    • 14.1.5.Recent Developments
    • 14.1.6.SWOT Analysis
  • 14.2.Abbott Laboratories Inc.
  • 14.3.Siemens Healthineers Ag
  • 14.4.F. Hoffmann-La Roche Ltd
  • 14.5.Quidel Corporation
  • 14.6.Danaher Corporation
  • 14.7.Becton, Dickinson and Company
  • 14.8.Thermo Fisher Scientific Inc
  • 14.9.Biomerieux S.A.
  • 14.10.Chembio Diagnostics, Inc.

15.Strategic Recommendations

16. About Us Disclaimer